Julie C. Qidwai

Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke

Patrick D. Lyden, Kent E. Pryor, Christopher S. Coffey et al. · Annals of Neurology · 2018 · 142 citations

Medicine, Pharmacology, Pharmacotherapy +17

Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia

Eric D. Foster, Nancy D. Bridges, Irene D. Feurer et al. · Diabetes Care · 2018 · 118 citations · Full text

Medicine, Endocrinology, Surgery +17

Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes

James F. Markmann, Michael R. Rickels, Thomas L. Eggerman et al. · American Journal of Transplantation · 2020 · 108 citations · Full text

Medicine, Endocrinology, Surgery +17

Long-term Outcomes With Islet-Alone and Islet-After-Kidney Transplantation for Type 1 Diabetes in the Clinical Islet Transplantation Consortium: The CIT-08 Study

Michael R. Rickels, Thomas L. Eggerman, Levent Bayman et al. · Diabetes Care · 2022 · 50 citations · Full text

Medicine, Endocrinology, Surgery +17

Consistency of Quantitative Scores of Hypoglycemia Severity and Glycemic Lability and Comparison with Continuous Glucose Monitoring System Measures in Long-Standing Type 1 Diabetes

Peter Senior, Melena D. Bellin, Rodolfo Alejandro et al. · Diabetes Technology & Therapeutics · 2015 · 30 citations · Full text

Medicine, Endocrinology, Internal Medicine +17